Neonatal Seizure
16
2
4
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (16)
Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy
Neonatal Seizure Registry - Developmental Functional EValuation
Evaluating the Role of Inflammation in Neonatal Epileptogenesis
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
Monitoring Key Activity and Physiology of Neonates in Intensive Care
Prospective Research in Infants With Mild Encephalopathy
Neonatal Seizures: Semiology, Etiology, Therapy and Prognosis Correlations
What Are the Determinant Factors of Ceasing Anti-seizure Medication in Infants With Neonatal Seizures?
AI-assisted cEEG Diagnosis of Neonatal Seizures in Neonatal Intensive Care Unit
The Effect of AI-assisted cEEG Diagnosis on the Administration of Antiseizure Medication in Neonatal Seizures
Evaluating the NeoTree in Malawi and Zimbabwe
Neonatal Seizures in NICU of Assuit University Children's Hospital
Maternal Hyperoxygenation for Intrapartum Fetal Heart Rate Tracing Abnormalities
Protecting Brains and Saving Futures - the PBSF Protocol
Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal Seizures
Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients.